[go: up one dir, main page]

RU99107569A - Фармацевтические композиции, обладающие антимикробной активностью - Google Patents

Фармацевтические композиции, обладающие антимикробной активностью

Info

Publication number
RU99107569A
RU99107569A RU99107569/14A RU99107569A RU99107569A RU 99107569 A RU99107569 A RU 99107569A RU 99107569/14 A RU99107569/14 A RU 99107569/14A RU 99107569 A RU99107569 A RU 99107569A RU 99107569 A RU99107569 A RU 99107569A
Authority
RU
Russia
Prior art keywords
antimicrobial activity
pharmaceutical compositions
zinc
complex
compositions possessing
Prior art date
Application number
RU99107569/14A
Other languages
English (en)
Other versions
RU2204394C2 (ru
Inventor
Янош Иллеш
Эржебет НЕШМЕЙИ
Бела СТЕФКО
Кальман БУРГЕР
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU9602498A external-priority patent/HU225329B1/hu
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт. filed Critical Рихтер Гедеон Ведьесети Дьяр Рт.
Publication of RU99107569A publication Critical patent/RU99107569A/ru
Application granted granted Critical
Publication of RU2204394C2 publication Critical patent/RU2204394C2/ru

Links

Claims (3)

1. Применение ассоциата (комплекса) гиалуроната цинка или кобальта для получения фармацевтической композиции, обладающей антимикробной активностью.
2. Применение ассоциата (комплекса) гиалуроната цинка или кобальта в качестве средства для лечения анаэробных бактериальных и/или грибковых инфекций также как желудочных и дуоденальных язв, вызванных Helicobacter pylori.
3. Способ предупреждения повторного инфицирования после лечения желудочных и дуоденальных язв, вызванных Helicobacter pylori, который включает назначение пациенту одной или более эффективной (ых) дозы (доз) соединения (комплекса) гиалуроната цинка или кобальта отдельно или в форме фармацевтической композиции.
RU99107569/14A 1996-09-12 1997-09-11 Средство для лечения грибковых инфекций, а также желудочных и дуоденальных язв, вызванных helicobacter pylori RU2204394C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP9602498 1996-09-12
HU9602498A HU225329B1 (en) 1996-09-12 1996-09-12 Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity

Publications (2)

Publication Number Publication Date
RU99107569A true RU99107569A (ru) 2001-02-20
RU2204394C2 RU2204394C2 (ru) 2003-05-20

Family

ID=89994266

Family Applications (1)

Application Number Title Priority Date Filing Date
RU99107569/14A RU2204394C2 (ru) 1996-09-12 1997-09-11 Средство для лечения грибковых инфекций, а также желудочных и дуоденальных язв, вызванных helicobacter pylori

Country Status (15)

Country Link
US (1) US6348190B1 (ru)
EP (1) EP0964687B1 (ru)
JP (2) JP2001500860A (ru)
KR (1) KR100489494B1 (ru)
CN (1) CN1130204C (ru)
AT (1) ATE254922T1 (ru)
AU (1) AU4469197A (ru)
DE (1) DE69726457T2 (ru)
DK (1) DK0964687T3 (ru)
ES (1) ES2212131T3 (ru)
HU (1) HU225329B1 (ru)
PT (1) PT964687E (ru)
RU (1) RU2204394C2 (ru)
UA (1) UA66766C2 (ru)
WO (1) WO1998010773A1 (ru)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225991B1 (en) * 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method
ITPD980168A1 (it) * 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Composizioni biocompatibili e biodegradabili comprendenti acido ialuronico e suoi derivati per il trattamento delle ulcere dell'appara
EP1143795A2 (en) * 1999-01-19 2001-10-17 Stericon, L.L.C. Hypertonic aqueous solutions of polybasic acid salts
GB0012487D0 (en) * 2000-05-24 2000-07-12 Pfylori Limited Use of metal compounds to treat gastrointestinal infections
FI20011403L (fi) 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
CN101374526B (zh) * 2006-01-27 2013-08-07 耶鲁大学 胃酸分泌的快速作用抑制剂
US8512761B2 (en) 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
WO2007091644A1 (ja) * 2006-02-10 2007-08-16 Seikagaku Corporation 真菌増殖抑制剤
US20070212420A1 (en) * 2006-03-10 2007-09-13 Bausch & Lomb Incorporated Pharmaceutical formulations comprising polyanionic materials and zinc-based preservatives
ITMI20061132A1 (it) * 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
WO2008036855A2 (en) * 2006-09-21 2008-03-27 Alcon Research, Ltd. Self-preserved aqueous pharmaceutical compositions
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
CN101522171A (zh) 2006-09-28 2009-09-02 爱尔康研究有限公司 自身防腐的水性药物组合物
TWI544927B (zh) 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
WO2009117242A2 (en) * 2008-03-17 2009-09-24 Alcon Research, Ltd. Aqueous pharmaceutical compositions containing borate-polyol complexes
TWI489997B (zh) 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
TWI383796B (zh) * 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
JP6081173B2 (ja) * 2011-12-12 2017-02-15 ロート製薬株式会社 眼科用水性組成物
WO2024223734A1 (en) * 2023-04-26 2024-10-31 Institut Curie Lymph node metal therapy for the treatment of cancer and immune-deficiency related disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623539A (en) 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
EP0259485A4 (en) * 1986-03-14 1988-07-29 Bio Technology General Corp HEAVY METAL SALTS OF HYALURONIC ACID FOR USE AS AN ANTIMICROBIAL AGENT.
US5472950A (en) * 1989-02-24 1995-12-05 Richter Gedeon Vegyeszeti Gyar Rt. Compositions containing cobalt hyaluronic acid complex
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
JPH0648950A (ja) * 1992-07-30 1994-02-22 Taito Kk 抗潰瘍剤

Similar Documents

Publication Publication Date Title
RU99107569A (ru) Фармацевтические композиции, обладающие антимикробной активностью
CA2140106A1 (en) Method of treating hyperproliferative vascular disease
CA2108903A1 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GEP20012578B (en) (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity
CA2370030A1 (en) Sodium channel blocker compositions and the use thereof
HK1094191A1 (en) Phenyl-carboxamide compounds useful for treating pain
AU2905092A (en) Pharmaceutical dipeptide compositions and methods of use thereof
FI963232A0 (fi) Antimikrobisena aineena käytettävä hapotettu nitriitti
CA2180535A1 (en) A method for treatment of psoriasis, by omeprazole or related compounds
BG103947A (en) Derivatives of 9-oxymerythromycin
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
KR880011197A (ko) 위장장해를 치료하기 위한 조성물 및 방법
WO2004011477A3 (en) 6,11-4-carbon bridged ketolides
CA2121345A1 (en) Lipophilic Oligosaccharide Antibiotic Salt Compositions
CA2284774A1 (en) Theobromine antitussive compositions
BG104434A (en) 2-halo-6-o-substituted ketolide derivatives
EE04953B1 (et) Tsinkhaluronaadi kasutamine ja meetod ravimkoostise valmistamiseks
AU4830097A (en) Use of an extract of Cimicifuga
DE69927584D1 (de) Pharmazeutische zubereitungen zur behandlung von magengeschwüren
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
EP0281070A3 (en) Pharmaceutical composition for the treatment of cancer
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
PL313078A1 (en) Novel bis-naphtalimides for use in treating carcinoma
WO1998006265A3 (en) Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
WO1990006307A3 (en) Antibacterial quinolone compounds